Sub: Annual Secretarial Compliance Report for the financial year ended March 31, 2025 Dear Sir/Madam, Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, prepared by SARK & Associates LLP, Company Secretaries. The review covered SEBI LODR regulations, insider trading rules, takeover code, and other applicable SEBI provisions. Two minor compliance lapses were flagged, both attracting small BSE standard operating procedure (SOP) fines: (1) a Rs. 53,100 fine for delayed submission of the Limited Review Report attached to half-yearly financial results for September 30, 2024, submitted 9 days late, and (2) a Rs. 5,900 fine for late XBRL filing of Related Party Transactions for FY March 2024, due to a technical upload error. Total penalties paid come to Rs. 59,000. Across all other checked areas — secretarial standards, insider trading, related party approvals, event disclosures, website maintenance, director eligibility, and performance evaluation — the company is reported as fully compliant.
These are routine procedural lapses with negligible financial impact (less than Rs. 60,000 in fines) and no effect on the company's business or shareholder value. The report confirms overall good standing with SEBI listing requirements, which is mildly positive for corporate governance perception.